Acrivon Therapeutics, Inc. (ACRV) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$77.91M | +3.3% |
| 2024 | -$80.56M | -33.4% |
| 2023 | -$60.39M | -93.8% |
| 2022 | -$31.17M | -91.9% |
| 2021 | -$16.24M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$77.91M | +3.3% |
| 2024 | -$80.56M | -33.4% |
| 2023 | -$60.39M | -93.8% |
| 2022 | -$31.17M | -91.9% |
| 2021 | -$16.24M | — |